이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Calumet Specialty Products Partners 대차 대조표 상태

재무 상태 기준 확인 1/6

Calumet Specialty Products Partners 의 총 주주 지분은 $-284.1M 이고 총 부채는 $2.1B, 이는 부채 대 자기자본 비율을 -751.4% 로 가져옵니다. 총자산과 총부채는 각각 $2.7B 및 $3.0B 입니다. Calumet Specialty Products Partners 의 EBIT는 $191.8M 이며 이자보상배율은 0.8 입니다. $23.9M 의 현금 및 단기 투자금을 보유하고 있습니다.

주요 정보

-751.4%

부채 비율

US$2.13b

부채

이자 보상 비율	0.8x
현금	US$23.90m
주식	-US$284.10m
총 부채	US$3.02b
총 자산	US$2.73b

최근 재무 상태 업데이트

업데이트 없음

Recent updates

Many Still Looking Away From Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT)

Jun 10

Calumet Specialty Products Endured Rainy Days With Blue Skies Ahead

May 19

Investors Will Want Calumet Specialty Products Partners' (NASDAQ:CLMT) Growth In ROCE To Persist

Apr 01

Calumet Specialty Products: Huge Increases In Cash Flows May Be Imminent [Downgrade]

Mar 18

LVS Advisory - Calumet: Fits Firmly Within The 'Moderate Risk, High Reward' Portfolio Bucket

Feb 11

재무 상태 분석

단기부채: CLMT 에는 음의 주주 지분이 있는데, 이는 단기 부채를 감당하지 못하는 단기 자산보다 더 심각한 상황입니다.

장기 부채: CLMT 의 주주 지분은 음수입니다. 이는 장기 부채를 감당하지 못하는 단기 자산보다 더 심각한 상황입니다.

부채 대 자본 내역 및 분석

부채 수준: CLMT 은 부정주주자본을 갖고 있는데, 이는 높은 부채 수준보다 더 심각한 상황입니다.

부채 감소: CLMT 의 주주 지분은 음수이므로 시간이 지남에 따라 부채가 감소했는지 확인할 필요가 없습니다.

대차 대조표

현금 런웨이 분석

과거에 평균적으로 적자를 기록했던 기업의 경우, 최소 1년 이상의 현금 유동성을 보유하고 있는지 평가합니다.

안정적인 현금 활주로: CLMT 현재 무료 현금 흐름을 기준으로 1년 미만의 cash runway를 보유하고 있습니다.

예측 현금 활주로: CLMT 48.2 1.2 48.2 % 매년.

Calumet Specialty Products Partners 대차 대조표 상태

재무 상태 기준 확인 1/6

주요 정보

최근 재무 상태 업데이트

Recent updates

Consensus EPS estimates fall by 19%

Price target decreased by 7.5% to US$20.90

Many Still Looking Away From Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT)

Consensus EPS estimates fall by 95%

Calumet Specialty Products Endured Rainy Days With Blue Skies Ahead

Senior VP recently sold US$167k worth of stock

First quarter 2024 earnings released: US$0.51 loss per share (vs US$0.35 profit in 1Q 2023)

Calumet Specialty Products Partners, L.P. to Report Q1, 2024 Results on May 10, 2024

Consensus EPS estimates increase from loss to US$0.226 profit

Investors Will Want Calumet Specialty Products Partners' (NASDAQ:CLMT) Growth In ROCE To Persist

Consensus EPS estimates upgraded to US$0.18 loss

Calumet Specialty Products: Huge Increases In Cash Flows May Be Imminent [Downgrade]

New major risk - Earnings quality

New minor risk - Earnings quality

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Calumet Specialty Products Partners, L.P. to Report Q4, 2023 Results on Feb 23, 2024

LVS Advisory - Calumet: Fits Firmly Within The 'Moderate Risk, High Reward' Portfolio Bucket

Calumet Specialty Products: Falling Knifes And Investor Irrationality

Chairman of the Board of Calumet GP exercised options and sold US$269k worth of stock

Consensus EPS estimates increase by 12%

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Calumet Specialty Products Partners, L.P. to Report Q3, 2023 Results on Nov 09, 2023

Calumet Specialty Products Partners, L.P. to Appoint David Lunin as EVP on January 1, 2024

Calumet Specialty Products Partners, L.P. Announces CFO Changes

Second quarter 2023 earnings: EPS misses analyst expectations

Calumet Specialty Products Partners, L.P. to Report Q2, 2023 Results on Aug 04, 2023

Insider recently bought US$82k worth of stock

First quarter 2023 earnings released: EPS: US$0.35 (vs US$1.18 loss in 1Q 2022)

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 25% undervalued

Price target decreased to US$25.28

Key Executive recently bought US$57k worth of stock

Less than half of directors are independent

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Calumet Specialty Products Partners, L.P. Appoints Steve Mawer as Chairman of the Board, Effective from January 1, 2023

Calumet Specialty Products Partners, L.P. to Report Q3, 2022 Results on Nov 09, 2022

Calumet Specialty Products Blasted Off, The Cash Flow Went Solar

Price target increased to US$26.20

Insider recently bought US$101k worth of stock

Second quarter 2022 earnings released: US$0.19 loss per share (vs US$0.97 loss in 2Q 2021)

Calumet Specialty Q2 2022 Earnings Preview

Calumet Specialty Products Partners, L.P. Announces Additions to Board of Directors

The Final Countdown For Calumet Specialty Products' Launch Continues

Calumet Specialty Products Partners, L.P. to Report Q2, 2022 Results on Aug 05, 2022

Consensus estimates of losses per share improve by 11%

Consensus estimates of losses per share improve by 14%

It's The Final Countdown For Calumet Specialty Products

Consensus forecasts updated

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus forecasts updated

Less than half of directors are independent

Consensus forecasts updated

Calumet Specialty Products Partners, L.P. to Report Q1, 2022 Results on May 06, 2022

Consensus forecasts updated

Calumet Specialty Products Partners, L.P. Always Landing On Its Feet

Full year 2021 earnings: EPS and revenues miss analyst expectations

Calumet Specialty Products Partners, L.P. Announces That Fred Fehsenfeld, Chairman of the Board of the General Partner Elected to Retire Effective May 1, 2022

Calumet Specialty Products Partners, L.P. to Report Q4, 2021 Results on Feb 25, 2022

Evaluating Calumet's Apparent Conservative Equity Valuation

Forecast breakeven date pushed back to 2023

Calumet Specialty Products Calls All Aboard

Price target decreased to US$19.10

Third quarter 2021 earnings released: EPS US$0.64 (vs US$0.70 loss in 3Q 2020)

Frantic Buying At Calumet Specialty Products

Price target increased to US$9.20

For Calumet, Progress Marches

Second quarter 2021 earnings released: US$0.97 loss per share (vs US$0.044 profit in 2Q 2020)

Consensus forecasts updated

Price target increased to US$7.00

Consensus EPS estimates fall to -US$2.31

More About Calumet's Duo Threaded Growth Businesses

Consensus forecasts updated

Consensus forecasts updated

First quarter 2021 earnings released: US$1.82 loss per share (vs US$0.18 loss in 1Q 2020)

Calumet Specialty EPS misses by $1.25, beats on revenue